| Ticker | $ Bought |
|---|---|
| celcuity inc | 38,854,400 |
| alkermes plc | 20,245,200 |
| henry schein inc | 14,548,800 |
| kenvue inc | 13,698,100 |
| gsk plc | 11,604,600 |
| haemonetics corp mass | 9,652,230 |
| kalvista pharmaceuticals inc | 8,328,920 |
| crinetics pharmaceuticals in | 7,282,130 |
| Ticker | % Inc. |
|---|---|
| sanofi sa | 200 |
| dianthus therapeutics inc | 144 |
| aquestive therapeutics inc | 58.11 |
| centene corp del | 47.66 |
| merck & co inc | 1.93 |
| maximus inc | 1.74 |
| Ticker | % Reduced |
|---|---|
| septerna inc | -67.63 |
| bright minds biosciences inc | -62.77 |
| aprea therapeutics inc | -59.83 |
| senseonics holdings inc | -52.28 |
| ani pharmaceuticals inc | -50.65 |
| edgewise therapeutics inc | -43.09 |
| ventyx biosciences inc | -36.61 |
| tyra biosciences inc | -36.45 |
| Ticker | $ Sold |
|---|---|
| annexon inc | -9,829,830 |
| alector inc | -1,183,740 |
| astria therapeutics inc | -1,705,850 |
| avanos med inc | -3,535,510 |
| globus med inc | -14,493,500 |
| mbx biosciences inc | -2,749,810 |
| enanta pharmaceuticals inc | -1,351,530 |
| artivion inc | -4,936,690 |
Sio Capital Management, LLC has about 53.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 53.5 |
| Others | 33.6 |
| Industrials | 12.9 |
Sio Capital Management, LLC has about 11.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 33.6 |
| MID-CAP | 28.2 |
| SMALL-CAP | 21.8 |
| LARGE-CAP | 7.8 |
| MEGA-CAP | 3.8 |
| MICRO-CAP | 3 |
| NANO-CAP | 1.8 |
About 57.5% of the stocks held by Sio Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 45.3 |
| Others | 42.5 |
| S&P 500 | 12.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Sio Capital Management, LLC has 51 stocks in it's portfolio. About 59.5% of the portfolio is in top 10 stocks. CNC proved to be the most loss making stock for the portfolio. MMS was the most profitable stock for Sio Capital Management, LLC last quarter.
Last Reported on: 13 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALGS | aligos therapeutics inc | 0.83 | 335,937 | 3,292,180 | unchanged | 0.00 | ||
| ALKS | alkermes plc | 5.12 | 674,840 | 20,245,200 | new | |||
| ANIP | ani pharmaceuticals inc | 1.29 | 55,723 | 5,104,230 | reduced | -50.65 | ||
| ANNX | annexon inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AORT | artivion inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APRE | aprea therapeutics inc | 0.04 | 112,223 | 165,529 | reduced | -59.83 | ||
| AQST | aquestive therapeutics inc | 2.12 | 1,498,100 | 8,374,350 | added | 58.11 | ||
| ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVNS | avanos med inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTX | avalo therapeutics inc | 0.23 | 72,173 | 917,319 | unchanged | 0.00 | ||
| BMRN | biomarin pharmaceutical inc | 3.08 | 225,114 | 12,192,200 | unchanged | 0.00 | ||
| CELC | celcuity inc | 9.83 | 786,526 | 38,854,400 | new | |||
| CNC | centene corp del | 3.50 | 387,600 | 13,829,600 | added | 47.66 | ||
| CNTX | context therapeutics inc | 0.33 | 1,341,640 | 1,299,780 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals in | 1.84 | 174,841 | 7,282,130 | new | |||
| EMBC | embecta corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ENTA | enanta pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ERAS | erasca inc | 0.76 | 1,369,750 | 2,986,050 | unchanged | 0.00 | ||
| EWTX | edgewise therapeutics inc | 1.26 | 307,181 | 4,982,480 | reduced | -43.09 | ||